Results 221 to 230 of about 26,970,723 (329)

Soft tissue augmentation procedures for natural teeth and dental implants: an overview of systematic reviews. [PDF]

Cochrane Database Syst Rev
Kuswandani SO, Buti J, Rotundo R, Hutomo DI, Tan HJ, D'Aiuto F.   +5 more
europepmc   +1 more source

MONTHLY REVIEW [PDF]

, 1939

openalex   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source

Highlighting the success of the Canadian Journal of Pain's inaugural Editorial Review Mentorship Program. [PDF]

Can J Pain
Pagé MG, Katz J.
europepmc   +1 more source

REVIEWS [PDF]

, 1959

openalex   +1 more source

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

Molecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop, Edgar Cardenas De La Hoz, Hanne Verswyvel, Joey De Backer, Ho Wa Lau, Angela Privat‐Maldonado, Wim Vanden Berghe, Steve Vanlanduit, Evelien Smits, Annemie Bogaerts, Abraham Lin   +10 more
wiley   +1 more source

Obiter Dicta [PDF]

, 1942
Law Review, Fordham
core   +4 more sources

Barriers and facilitators of HIV pre-exposure prophylaxis (PrEP) uptake and use in Canada: a scoping review protocol. [PDF]

BMJ Open
Chabikuli A, Chakraborty D, Ziegler C, Djiadeu P, Mgbatogu K, Ifeanacho E, Ajiboye O, Lo Hog Tian J, Odhiambo J, Nelson LE, Rourke SB, Ajiboye W.   +11 more
europepmc   +1 more source

Molecular imaging predicts trastuzumab‐deruxtecan (T‐DXd) response in head and neck cancer xenograft models

Molecular Oncology, EarlyView.
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed, Lucas Mani, Muhammad Bilal Mirza, Ashtyn McAdoo, Takahito Kondo, Hidenori Tanaka, Nicole Meeks, Eben Rosenthal, Marisa Hom   +8 more
wiley   +1 more source

A framework for clinical care pathway renewal: an example from inflammatory bowel disease. [PDF]

BMC Med Res Methodol
Chappell KD, Olayinka L, Sutton R, Seow CH, deBruyn J, van Zanten SV, Ma C, Halloran B, Dieleman LA, Wong K, Panaccione R, Kroeker KI.   +11 more
europepmc   +1 more source